Altered Biodistribution on FDG-PET with Emphasis on Brown Fat and Insulin Effect

Seminars in Nuclear Medicine

Volumn 40, Issue 4, 2010, Pages 283-293

  Cohade, Christian ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLONY STIMULATING FACTOR; DIAZEPAM; FENTANYL; FLUORODEOXYGLUCOSE F 18; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; PLACEBO; PROPRANOLOL; SHORT ACTING DRUG; UNCOUPLING PROTEIN 1; RADIOPHARMACEUTICAL AGENT;

BETA ADRENERGIC RECEPTOR BLOCKING; BONE MARROW; BREAST CANCER; BROWN ADIPOSE TISSUE; CLINICAL TRIAL; COLD EXPOSURE; COMPUTER ASSISTED TOMOGRAPHY; DIET; DRUG DISTRIBUTION; DRUG UPTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMAGE ANALYSIS; IMAGE QUALITY; INCIDENCE; INSULIN SENSITIVITY; INTESTINE; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; NEUTROPENIA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; THERMOGENESIS; URINARY TRACT; WARMING; ARTIFACT; DIAGNOSTIC USE; DRUG EFFECTS; METABOLISM; PROCEDURES; SCINTISCANNING; TISSUE DISTRIBUTION;

ADIPOSE TISSUE, BROWN; ARTIFACTS; FLUORODEOXYGLUCOSE F18; HUMANS; INSULIN; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 77952692243     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2010.02.001     Document Type: Review

References (69)

1. Barrington S.F., and Maisey M.N. Skeletal muscle uptake of fluorine-18-FDG: Effect of oral diazepam. J Nucl Med 37 (1996) 1127-1129
2. Bar-Shalom R. Muscle uptake of 18-fluorine fluorodeoxyglucose. Semin Nucl Med 30 (2000) 306-309
3. Lindholm P., Minn H., Leskinen-Kallio S., et al. Influence of the blood glucose concentration on FDG uptake in cancer-A PET study. J Nucl Med 34 (1993) 1-6
4. Torizuka T., Zasadny K.R., and Wahl R.L. Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging 2 (1999) 281-287
5. Diederichs C.G., Staib L., Glatting G., et al. FDG PET: Elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 39 (1998) 1030-1033
6. Gorenberg M., Hallett W.A., and O'Doherty M.J. Does diabetes affect [(18)F]FDG standardised uptake values in lung cancer?. Eur J Nucl Med Mol Imaging 29 (2002) 1324-1327
7. Chang Y.C., Yen T.C., Ng K.K., et al. Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?. Eur J Nucl Med Mol Imaging 32 (2005) 647-652
8. Hara T., Higashi T., Nakamoto Y., et al. Significance of chronic marked hyperglycemia on FDG-PET: Is it really problematic for clinical oncologic imaging?. Ann Nucl Med 23 (2009) 657-669
9. Torizuka T., Clavo A.C., and Wahl R.L. Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine. J Nucl Med 38 (1997) 382-386
10. Delbeke D., Coleman R.E., Guiberteau M.J., et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med 47 (2006) 885-895
11. Varrone A., Asenbaum S., Vander Borght T., et al. EANM procedure guidelines for PET brain imaging using [(18)F]FDG, version 2. Eur J Nucl Med Mol Imaging 36 (2009) 2103-2110
12. Turcotte E., Leblanc M., Carpentier A., et al. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-D-glucose injection following I.V. insulin in diabetic patients. Mol Imaging Biol 8 (2006) 348-354
13. Roy F.N., Beaulieu S., Boucher L., et al. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients. J Nucl Med 50 (2009) 178-183
14. Niederkohr R.D., and Quon A. No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine. Clin Nucl Med 32 (2007) 302-303
15. Virtanen K.A., Lonnroth P., Parkkola R., et al. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab 87 (2002) 3902-3910
16. Viljanen A.P., Virtanen K.A., Jarvisalo M.J., et al. Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: A double-blind, randomized study with metformin. J Clin Endocrinol Metab 90 (2005) 6523-6528
17. Hany T.F., Gharehpapagh E., Kamel E.M., et al. Brown adipose tissue: A factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 29 (2002) 1393-1398
18. Cohade C., Osman M., Pannu H.K., et al. Uptake in supraclavicular area fat ("US-Fat"): Description on 18F-FDG PET/CT. J Nucl Med 44 (2003) 170-176
19. Huttunen P., Hirvonen J., and Kinnula V. The occurrence of brown adipose tissue in outdoor workers. Eur J Appl Physiol Occup Physiol 46 (1981) 339-345
20. Tatsumi M., Engles J.M., Ishimori T., et al. Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 45 (2004) 1189-1193
21. Belhocine T., Shastry A., Driedger A., et al. Detection of 99mTc-sestamibi uptake in brown adipose tissue with SPECT-CT. Eur J Nucl Med Mol Imaging 34 (2007) 149
22. Gelfand M.J. 123I-mIBG uptake in the neck and shoulders of a neuroblastoma patient: Damage to sympathetic innervation blocks uptake in brown adipose tissue. Pediatr Radiol 34 (2004) 577-579
23. Hadi M., Chen C.C., Whatley M., et al. Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-mIBG SPECT: A study of patients being evaluated for pheochromocytoma. J Nucl Med 48 (2007) 1077-1083
24. Higuchi T., Kinuya S., Taki J., et al. Brown adipose tissue: Evaluation with 201Tl and 99mTc-sestamibi dual-tracer SPECT. Ann Nucl Med 18 (2004) 547-549
25. Kyparos D., Arsos G., Georga S., et al. Assessment of brown adipose tissue activity in rats by 99mTc-sestamibi uptake. Physiol Rev 55 (2006) 653-659
26. Virtanen K.A., Lidell M.E., Orava J., et al. Functional brown adipose tissue in healthy adults. N Engl J Med 360 (2009) 1518-1525
27. Lowell B.B., and Spiegelman B.M. Towards a molecular understanding of adaptive thermogenesis. Nature 404 (2000) 652-660
28. Nedergaard J., Bengtsson T., and Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293 (2007) E444-E452
29. Ma S.W. Foster DO uptake of glucose and release of fatty acids and glycerol by rat brown adipose tissue in vivo. Can J Physiol Pharmacol 64 (1986) 609-614
30. Cannon B., and Nedergaard J. Brown adipose tissue: Function and physiological significance. Physiol Rev 84 (2004) 277-359
31. Cohade C., Mourtzikos K.A., and Wahl R.L. "US-Fat": Prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J Nucl Med 44 (2003) 1267-1270
32. Rousseau C., Bourbouloux E., Campion L., et al. Brown fat in breast cancer patients: Analysis of serial (18)F-FDG PET/CT scans. Eur J Nucl Med Mol Imaging 33 (2006) 785-791
33. Kim S., Krynyckyi B.R., Machac J., et al. Temporal relation between temperature change and FDG uptake in brown adipose tissue. Eur J Nucl Med Mol Imaging 35 (2008) 984-989
34. Saito M., Okamatsu-Ogura Y., Matsushita M., et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: Effects of cold exposure and adiposity. Diabetes 58 (2009) 1526-1531
35. Au-Yong I.T., Thorn N., Ganatra R., et al. Brown adipose tissue and seasonal variation in humans. Diabetes 58 (2009) 2583-2587
36. McDonald R.B., Murtagh C.M., and Horwitz B.A. Age and gender effects on glucose utilization in skeletal muscle and brown adipose tissue of cold-exposed rats. Proc Soc Exp Biol Med 207 (1994) 102-109
37. Yeung H.W., Grewal R.K., Gonen M., et al. Patterns of (18)F-FDG uptake in adipose tissue and muscle: A potential source of false-positives for PET. J Nucl Med 44 (2003) 1789-1796
38. Gelfand M.J., O'Hara S.M., Curtwright L.A., et al. Pre-medication to block [(18)F]FDG uptake in the brown adipose tissue of pediatric and adolescent patients. Pediatr Radiol 35 (2005) 984-990
39. van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med 360 (2009) 1500-1508
40. Iyer R.B., Guo C.C., and Perrier N. Adrenal pheochromocytoma with surrounding brown fat stimulation. AJR Am J Roentgenol 192 (2009) 300-301
41. Bar-Shalom R., Gaitini D., Keidar Z., et al. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: A new site of physiological tracer biodistribution characterised by PET/CT. Eur J Nucl Med Mol Imaging 31 (2004) 1105-1113
42. Truong M.T., Erasmus J.J., Munden R.F., et al. Focal FDG uptake in mediastinal brown fat mimicking malignancy: A potential pitfall resolved on PET/CT. AJR Am J Roentgenol 183 (2004) 1127-1132
43. Fan C.M., Fischman A.J., Kwek B.H., et al. Lipomatous hypertrophy of the interatrial septum: Increased uptake on FDG PET. AJR Am J Roentgenol 184 (2005) 339-342
44. Kuester L.B., Fischman A.J., Fan C.M., et al. Lipomatous hypertrophy of the interatrial septum: Prevalence and features on fusion 18F fluorodeoxyglucose positron emission tomography/CT. Chest 128 (2005) 3888-3893
45. Hoffmann C., Leitz M.R., Oberdorf-Maass S., et al. Comparative pharmacology of human beta-adrenergic receptor subtypes-Characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 369 (2004) 151-159
46. Soderlund V., Larsson S.A., and Jacobsson H. Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol. Eur J Nucl Med Mol Imaging 34 (2007) 1018-1022
47. Parysow O., Mollerach A.M., Jager V., et al. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med 32 (2007) 351-357
48. Agrawal A., Nair N., and Baghel N.S. A novel approach for reduction of brown fat uptake on FDG PET. Br J Radiol 82 (2009) 626-631
49. Hirsch J.D. Pharmacological and physiological properties of benzodiazepine binding sites in rodent brown adipose tissue. Comp Biochem. Physiologist C 77 (1984) 339-343
50. Sturkenboom M.G., Hoekstra O.S., Postema E.J., et al. A randomised controlled trial assessing the effect of oral diazepam on 18F-FDG uptake in the neck and upper chest region. Mol Imaging Biol 11 (2009) 364-368
51. Baba S., Tatsumi M., Ishimori T., et al. Effect of nicotine and ephedrine on the accumulation of 18F-FDG in brown adipose tissue. J Nucl Med 48 (2007) 981-986
52. Williams G., and Kolodny G.M. Method for decreasing uptake of 18F-FDG by hypermetabolic brown adipose tissue on PET. AJR Am J Roentgenol 190 (2008) 1406-1409
53. Williams G., and Kolodny G.M. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol 190 (2008) W151-W156
54. Garcia C.A., Van Nostrand D., Atkins F., et al. Reduction of brown fat 2-deoxy-2-[F-18]fluoro-d-glucose uptake by controlling environmental temperature prior to positron emission tomography scan. Mol Imaging Biol 8 (2006) 24-29
55. Zukotynski K.A., Fahey F.H., Laffin S., et al. Constant ambient temperature of 24 degrees C significantly reduces FDG uptake by brown adipose tissue in children scanned during the winter. Eur J Nucl Med Mol Imaging 36 (2009) 602-606
56. Skarulis M.C., Celi F.S., Mueller E., et al. Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance. J Clin Endocrinol Metab 95 (2010) 256-262
57. Sugawara Y., Fisher S.J., Zasadny K.R., et al. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol 16 (1998) 173-180
58. Sugawara Y., Zasadny K.R., Kison P.V., et al. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. J Nucl Med 40 (1999) 1456-1462
59. Hollinger E.F., Alibazoglu H., Ali A., et al. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med 23 (1998) 93-98
60. Kazama T., Swanston N., Podoloff D.A., et al. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging 32 (2005) 1406-1411
61. Jacene H.A., Ishimori T., Engles J.M., et al. Effects of pegfilgrastim on normal biodistribution of 18F-FDG: Preclinical and clinical studies. J Nucl Med 47 (2006) 950-956
62. Goethals I., Hoste P., De Vriendt C., et al. Time-dependent changes in (18)F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma. Eur J Nucl Med Mol Imaging 37 (2010) 462-467
63. Plantade A., Montravers F., Selle F., et al. Diffusely increased F-18 FDG uptake in bone marrow in a patient with acute anemia and recent erythropoietin therapy. Clin Nucl Med 28 (2003) 771-772
64. Blodgett T.M., Ames J.T., Torok F.S., et al. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Clin Nucl Med 29 (2004) 161-163
65. Prevost S., Boucher L., Larivee P., et al. Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer. J Nucl Med 47 (2006) 559-565
66. Van de Wiele C., Vandevyver F., Debruyne C., et al. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels. Eur J Nucl Med Mol Imaging 35 (2008) 519-522
67. Gontier E., Fourme E., Wartski M., et al. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging 35 (2008) 95-99
68. Minamimoto R., Takahashi N., and Inoue T. FDG-PET of patients with suspected renal failure: Standardized uptake values in normal tissues. Ann Nucl Med 21 (2007) 217-222
69. Laffon E., Cazeau A.L., Monet A., et al. The effect of renal failure on 18F-FDG uptake: A theoretic assessment. J Nucl Med Technol 36 (2008) 200-202